info@marketreportsonchina.com

Investigation Report on China ribonucleic acid II (RNAII) for Injection [2010-2019]

Press Release   •   Dec 23, 2015 11:58 IST

Dec., 23, 2015, Mumbai, India: Market Reports on China presents the report, on “Investigation Report on China ribonucleic acid II (RNAII) for Injection [2010-2019]”. RNAII for injection develops fast in China with sales value rising from less than CNY 60 million in 2005 to about CNY 500 million in 2014 and CAGR during this period reaching 80%.

RNAII for injection, one kind of immunomodulator, can improve body immunity and inhibit tumor by causing vacuolar degeneration and colliquative necrosis in tumor cells as well as generating large amounts of hyperplastic fibroblasts, macrophages, lymphocytes or even connective tissue to substitute tumor tissue. And it is used for the adjuvant treatment of pancreatic cancer, liver cancer, stomach cancer, breast cancer, soft tissue sarcoma and other cancers especially hepatitis B.
RNAII for injection can also be used for the treatment of various diseases caused by low immune function.

According to market survey, RNAII for injection develops fast in China with sales value rising from less than CNY 60 million in 2005 to about CNY 500 million in 2014 and CAGR during this period reaching 80%.

With the lifestyle changes brought about by economic development as well as the serious environmental pollution, the incidence of cancer keeps increasing with the number of new cases exceeding 3 million each year in China. Meanwhile, there are over 90 million hepatitis B patients in China too. Therefore, the market size of RNAII for injection is expected to keep growing in the next few years in China.

Readers can get at least the following information from this report:
-market size of RNAII for injection in China
-competitive landscape of RNAII for injection in Chinese market
-price of RNAII for injection made by different enterprises in China
-market outlook of RNAII for injection in China

The author suggests the following groups of people purchase this report:
-manufacturers of immunomodulator
-investors/ research institutions interested in Chinese medicine market
-any interest in the Chinese medicine market, please contact for customized survey service

Table of Contents

1 Related Concepts of RNAII for Injection
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of RNAII for Injection in China
2.1 Patent and Approval Status of RNAII for Injection in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of RNAII for Injection in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

To view a full Executive Summary and Table of Contents, please visit:http://www.marketreportsonchina.com/life-sciences-market-research-reports-16679/investigation-china-ribonucleic-acid.html

Related Reports:http://www.marketreportsonchina.com/market-research-report/life-sciences.html

About Author Bio: Sarah Davis is working with MarketReportsonChina which is a portal where you can access thousands of reports on China starting from Aeronautics to Zinc (A-Z). The website provides market reports on different sectors.

Contact Us
Market Reports on China
Contact No: India: +91.22.27810773
Email: info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com/about.php
Twitter: https://twitter.com/ReportsonChina